Cooper Companies (The) (COO) stock: analyst price target and their real reliability

Live quote · data updated Oct 14, 2026
Cooper Companies (The) · Health Care · ref. ETF XLV · 50 calls · price $54.59
💬JPI AI AssistantTry it →
What the company does: The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.

📈 Cooper Companies (The) (COO) stock price

$54.59-23.3% over range
Oct 14, 25low $53.27 · high $84.32Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
31% recommend buying · 13 analysts
📊 JPI status : Cooper Companies (The) has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 COO price target & analyst consensus — price $54.59

The price target · all analysts combined (12 targets)
Highest target · 1 firm of 12$92+68.5%
Median target · of 12 targets$63+15.4%
Lowest target · 1 firm of 12$58+6.2%
Current price$54.59
Where these 12 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 12100% $58 ↔ $92
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: JP Morgan — 68% of its targets hit on this sector (364 calls tested). It aims for $58 (+6.2 %), call made on September 11, 2026, maturing on September 11, 2027 (33 d ago).

The 11 reliable analysts $61+12 %
The 1 other firm $92+69 %
How to read it: the 11 reliable firms are not filtered by optimism — 11 aim above the price, 0 below, hence their $61 median. “The 1 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 13 ratings (last 6 months)
Strong Buy00%
Buy431%
Hold969%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Cooper Companies (The)? The JPI assistant answers using our backtest data.

📈 Cooper Companies (The) fundamentals: valuation, margins & growth › open the full page

P/E 19.1Net margin 13.5 %Revenue growth +0.6 %Cheap for the growth

Revenue, net income and margin per year

Revenue Net income · hover a bar for details
2022
marg. 12 %
2023
Rev +9%Profit −24%
2024
Rev +8%Profit +33%
2025
Rev +5%Profit −4%

🏛️ Cooper Companies (The) insider buying: who's buying and how much › open the full page

3 insiders bought4 buys / 6 mo $1.9M👥 Cluster buy

🔎 Detailed analyses

🏛️ Which US Congress members hold Cooper Companies (The) (COO)?

1 Congress member has disclosed COO buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Gilbert Cisneros 3× · 48%
→ Full members ranking (who beats the market)

✅ Historical analyst reliability on COO

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm ↕ % right i ↕ Gain vs sector i ↕ Calls i ↕
Stifel ↗ 50% +2.5% 2
Needham ↗ 50% +2.4% 2
Piper Sandler ↗ 33% -3.8% 3
Baird ↗ 33% -5.7% 3
Wells Fargo ↗ 33% -9.2% 3
Citigroup ↗ 0% -16.1% 2

📊 What $1,000 invested in Cooper Companies (The) would be worth › open the full page

In short — $1,000 invested in Cooper Companies (The) 10 years ago would be worth $2,137 today, i.e. +8%/yr on average. Best year: 2016 (+30%), worst: 2022 (-21%). Price performance, excluding dividends.

If I'd invested $1,000 in Cooper Companies (The)

InvestmentWorth todayGain
1 years ago$780-22%
3 years ago$867-13%
5 years ago$789-21%
→ See Cooper Companies (The)'s full return history + gain calculator

Return by year (Cooper Companies (The))

YearReturn$1,000 invested at year start
2026 (YTD)-13%$875 (-13%)
2025-11%$780 (-22%)
2024-3%$758 (-24%)
→ See Cooper Companies (The)'s full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Cooper Companies (The)

Loading news…

📋 All analyst calls on COO

Barclays ↗
Oct 7, 26
■ Equal-Weight neutral · not a buy · 🎯$60
Price at call : $54.75 — gap to target +10%
Today : $54.59 — gap to target +10%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 7, 27
Needham ↗
Sep 15, 26
▲ Buy · 🎯$73
Price at call : $53.27 — upside +37%
Today : $54.59 — upside +34%
🎯 on COO : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Sep 15, 27
Mizuho ↗
Sep 11, 26
▲ Outperform · 🎯$75
Price at call : $54.22 — upside +38%
Today : $54.59 — upside +37%
🎯 on COO : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Sep 11, 27
William Blair ↗
Sep 10, 26
■ Market Perform neutral · not a buy
🎯 on COO : no call matured yet · 📊 on Health : 64.3% · +7.1% (28 calls)
in progress (365j)
matures : Sep 10, 27
Wells Fargo ↗
Sep 10, 26
■ Equal-Weight neutral · not a buy · 🎯$61
Price at call : $53.91 — gap to target +13%
Today : $54.59 — gap to target +12%
🎯 on COO : 100% (1 call matured) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Sep 10, 27
Stifel ↗
Sep 10, 26
▲ Buy · 🎯$70
Price at call : $53.91 — upside +30%
Today : $54.59 — upside +28%
🎯 on COO : 100% (1 call matured) · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Sep 10, 27
Citigroup ↗
Sep 10, 26
■ Neutral neutral · not a buy · 🎯$60
Price at call : $53.91 — gap to target +11%
Today : $54.59 — gap to target +10%
🎯 on COO : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Sep 10, 27
Piper Sandler ↗
Sep 10, 26
■ Neutral neutral · not a buy · 🎯$59
Price at call : $53.91 — gap to target +9%
Today : $54.59 — gap to target +8%
🎯 on COO : 100% (1 call matured) · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Sep 10, 27
See the other 42 calls, newest to oldest
JP Morgan ↗
Sep 10, 26
■ Neutral neutral · not a buy · 🎯$58
Price at call : $53.91 — gap to target +8%
Today : $54.59 — gap to target +6%
🎯 on COO : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Sep 10, 27
UBS ↗
Sep 10, 26
■ Neutral neutral · not a buy · 🎯$66
Price at call : $53.91 — gap to target +22%
Today : $54.59 — gap to target +21%
🎯 on COO : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Sep 10, 27
■ Neutral neutral · not a buy · 🎯$65
Price at call : $54.17 — gap to target +20%
Today : $54.59 — gap to target +19%
🎯 on COO : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Sep 10, 27
Baird ↗
Sep 10, 26
■ Neutral neutral · not a buy · 🎯$61
Price at call : $54.17 — gap to target +13%
Today : $54.59 — gap to target +12%
🎯 on COO : 100% (1 call matured) · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Sep 10, 27
Needham ↗
Sep 10, 26
▲ Buy · 🎯$73
Price at call : $54.17 — upside +35%
Today : $54.59 — upside +34%
🎯 on COO : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Sep 10, 27
Citigroup ↗
Aug 13, 26
■ Neutral neutral · not a buy · 🎯$80
Price at call : $76.17 — gap to target +5%
Today : $54.59 — gap to target +47%
🎯 on COO : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Aug 13, 27
UBS ↗
Jul 28, 26
■ Neutral neutral · not a buy · 🎯$75
Price at call : $73.06 — gap to target +3%
Today : $54.59 — gap to target +37%
🎯 on COO : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jul 28, 27
Citigroup ↗
Jul 8, 26
■ Neutral neutral · not a buy · 🎯$76
Price at call : $71.02 — gap to target +7%
Today : $54.59 — gap to target +39%
🎯 on COO : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Jul 8, 27
BNP Paribas
Jun 8, 26
▲ Outperform · 🎯$92
Price at call : $68.62 — upside +34%
Today : $54.59 — upside +69%
🎯 on COO : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jun 8, 27
JP Morgan ↗
Jun 5, 26
■ Neutral neutral · not a buy · 🎯$71
Price at call : $66.79 — gap to target +6%
Today : $54.59 — gap to target +30%
🎯 on COO : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Jun 5, 27
Stifel ↗
Jun 5, 26
▲ Buy · 🎯$85
Price at call : $66.79 — upside +27%
Today : $54.59 — upside +56%
🎯 on COO : 100% (1 call matured) · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Jun 5, 27
Wells Fargo ↗
Jun 5, 26
■ Equal-Weight neutral · not a buy · 🎯$66
Price at call : $66.79 — gap to target -1%
Today : $54.59 — gap to target +21%
🎯 on COO : 100% (1 call matured) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jun 5, 27
Needham ↗
Jun 5, 26
▲ Buy · 🎯$86
Price at call : $67.34 — upside +28%
Today : $54.59 — upside +58%
🎯 on COO : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Jun 5, 27
Baird ↗
Jun 5, 26
▲ Outperform · 🎯$85
Price at call : $67.34 — upside +26%
Today : $54.59 — upside +56%
🎯 on COO : 100% (1 call matured) · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Jun 5, 27
Mizuho ↗
Jun 4, 26
▲ Outperform · 🎯$85
Price at call : $67.34 — upside +26%
Today : $54.59 — upside +56%
🎯 on COO : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Jun 4, 27
Piper Sandler ↗
Jun 1, 26
▲ Overweight · 🎯$86
Price at call : $59.49 — upside +45%
Today : $54.59 — upside +58%
🎯 on COO : 100% (1 call matured) · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Jun 1, 27
Citigroup ↗
May 28, 26
■ Neutral neutral · not a buy · 🎯$69
Price at call : $61.21 — gap to target +13%
Today : $54.59 — gap to target +26%
🎯 on COO : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : May 28, 27
Citigroup ↗
Mar 6, 26
■ Neutral neutral · not a buy · 🎯$87
Price at call : $75.82 — gap to target +15%
Today : $54.59 — gap to target +59%
🎯 on COO : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Mar 6, 27
Barclays ↗
Mar 6, 26
▲ Overweight · 🎯$103
Price at call : $75.82 — upside +36%
Today : $54.59 — upside +89%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Mar 6, 27
Needham ↗
Mar 6, 26
▲ Buy · 🎯$101
Price at call : $76.55 — upside +32%
Today : $54.59 — upside +85%
🎯 on COO : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Mar 6, 27
Needham ↗
Feb 3, 26
▲ Buy · 🎯$99
Price at call : $79.33 — upside +25%
Today : $54.59 — upside +81%
🎯 on COO : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Feb 3, 27
Barclays ↗
Jan 26, 26
▲ Overweight · 🎯$98
Price at call : $80.7 — upside +21%
Today : $54.59 — upside +80%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jan 26, 27
Citigroup ↗
Dec 8, 25
■ Neutral neutral · not a buy · 🎯$88
Price at call : $78.51 — gap to target +12%
Today : $54.59 — gap to target +61%
🎯 on COO : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Dec 8, 26
■ Equal-Weight neutral · not a buy · 🎯$83
Price at call : $78.51 — gap to target +6%
Today : $54.59 — gap to target +52%
🎯 on COO : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Dec 8, 26
Goldman Sachs ↗
Dec 8, 25
▼ Sell · 🎯$71
Price at call : $78.51 — upside -10%
Today : $54.59 — upside +30%
🎯 on COO : 100% (1 call matured) · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Dec 8, 26
Stifel ↗
Dec 5, 25
▲ Buy · 🎯$95
Price at call : $78.04 — upside +22%
Today : $54.59 — upside +74%
🎯 on COO : 100% (1 call matured) · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Dec 5, 26
Piper Sandler ↗
Dec 5, 25
▲ Overweight · 🎯$94
Price at call : $78.04 — upside +20%
Today : $54.59 — upside +72%
🎯 on COO : 100% (1 call matured) · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Dec 5, 26
Wells Fargo ↗
Dec 5, 25
■ Equal-Weight neutral · not a buy · 🎯$82
Price at call : $78.04 — gap to target +5%
Today : $54.59 — gap to target +50%
🎯 on COO : 100% (1 call matured) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Dec 5, 26
JP Morgan ↗
Dec 5, 25
■ Neutral neutral · not a buy · 🎯$78
Price at call : $78.04 — gap to target -0%
Today : $54.59 — gap to target +43%
🎯 on COO : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Dec 5, 26
Mizuho ↗
Dec 5, 25
▲ Outperform · 🎯$100
Price at call : $81.4 — upside +23%
Today : $54.59 — upside +83%
🎯 on COO : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Dec 5, 26
Baird ↗
Dec 5, 25
▲ Outperform · 🎯$98
Price at call : $81.4 — upside +20%
Today : $54.59 — upside +80%
🎯 on COO : 100% (1 call matured) · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Dec 5, 26
Needham ↗
Dec 5, 25
▲ Buy · 🎯$100
Price at call : $81.4 — upside +23%
Today : $54.59 — upside +83%
🎯 on COO : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Dec 5, 26
Wells Fargo ↗
Nov 13, 25
■ Equal-Weight neutral · not a buy · 🎯$72
Price at call : $71.75 — gap to target +0%
Today : $54.59 — gap to target +32%
🎯 on COO : 100% (1 call matured) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Nov 13, 26
Barclays ↗
Oct 13, 25
▲ Overweight · 🎯$85
Price at call : $69.3 — upside +23%
Today : $54.59 — upside +56%
Expected +23% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (1 call matured) · 📊 on Health : 50.1% · +2.0% (645 calls)
-21.2%
stock -21% · XLV +20%
matured Oct 13, 26
Goldman Sachs ↗
Oct 1, 25
▼ Sell · 🎯$64
Price at call : $69.12 — upside -7%
Today : $54.59 — upside +17%
Expected -7% · Actual -18% · Reason (≤ −15%) : ✓ Yes
🎯 on COO : 100% (1 call matured) · 📊 on Health : 51.4% · +2.3% (243 calls)
+17.7%
stock -18% · XLV +16%
matured Oct 1, 26
JP Morgan ↗
Aug 28, 25
■ Neutral neutral · not a buy · 🎯$66
Price at call : $67.4 — gap to target -2%
Today : $54.59 — gap to target +21%
🎯 on COO : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Aug 28, 26
Morgan Stanley ↗
Aug 28, 25
■ Equal-Weight neutral · not a buy · 🎯$76
Price at call : $67.4 — gap to target +13%
Today : $54.59 — gap to target +39%
🎯 on COO : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Aug 28, 26
Baird ↗
Aug 28, 25
▲ Outperform · 🎯$85
Price at call : $67.4 — upside +26%
Today : $54.59 — upside +56%
Expected +26% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on COO : 100% (1 call matured) · 📊 on Health : 51.3% · +6.1% (302 calls)
+4.0%
stock +4% · XLV +24%
matured Aug 28, 26
Wells Fargo ↗
Aug 28, 25
▲ Overweight · 🎯$72
Price at call : $67.4 — upside +7%
Today : $54.59 — upside +32%
Expected +7% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on COO : 100% (1 call matured) · 📊 on Health : 47.6% · +1.0% (403 calls)
+4.0%
stock +4% · XLV +24%
matured Aug 28, 26
Piper Sandler ↗
Aug 28, 25
▲ Overweight · 🎯$83
Price at call : $67.4 — upside +23%
Today : $54.59 — upside +52%
Expected +23% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on COO : 100% (1 call matured) · 📊 on Health : 46.6% · -1.4% (324 calls)
+4.0%
stock +4% · XLV +24%
matured Aug 28, 26
Stifel ↗
Aug 28, 25
▲ Buy · 🎯$85
Price at call : $64.58 — upside +32%
Today : $54.59 — upside +56%
Expected +32% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on COO : 100% (1 call matured) · 📊 on Health : 50.7% · +7.8% (304 calls)
+10.2%
stock +10% · XLV +25%
matured Aug 28, 26
Citigroup ↗
Aug 28, 25
■ Neutral neutral · not a buy · 🎯$72
Price at call : $64.58 — gap to target +11%
Today : $54.59 — gap to target +32%
🎯 on COO : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Aug 28, 26

Frequently asked questions

Should I buy Cooper Companies (The) stock?

This isn't buy advice. For Cooper Companies (The), the analyst consensus is "Hold", with an average price target of $63.00 (+15% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 50% of the time (2 calls tracked on Cooper Companies (The)). We show the numbers — you decide.

Is it too late to buy Cooper Companies (The)? How high can it go?

The most bullish analyst target on Cooper Companies (The) is $92.00 (+69% above today's price); the average is $63.00. That's the upside they see. Check how reliable those analysts have actually been on Cooper Companies (The) on our site before trusting it.

Is Cooper Companies (The) still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 6 analysts have a real record on Cooper Companies (The), the best hitting 50% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.

Will Cooper Companies (The) stock recover (go back up)?

It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will COO stock recover (go back up)?

Should you invest in Cooper Companies (The)? The case for and against

The arguments for and against, one by one, from the numbers: why invest in COO (and why hesitate).

What has Cooper Companies (The)'s past performance been?

Historical returns and a "how much if I had invested" calculator: COO performance & returns.

Are insiders buying COO stock?

Executives' and large holders' buys and sells, decoded: insider buying on COO.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)